Back to PollNow

Back to companies

Nanobiotix S.A.

NBTXFRNASDAQPharmaceuticals & Healthcare

Nanobiotix S.A.

Revenue

€32.6mn

YoY +553.2%

Operating income

-€10.8mn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API